<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03101592</url>
  </required_header>
  <id_info>
    <org_study_id>16-001652</org_study_id>
    <nct_id>NCT03101592</nct_id>
  </id_info>
  <brief_title>INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV</brief_title>
  <acronym>INTERVAL</acronym>
  <official_title>INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Equip, Lesotho</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Malawi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Zambia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Partners in Hope</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Right to Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an unblinded cluster-randomized study to evaluate the effectiveness of two strategies&#xD;
      for scripting/dispensing of antiretroviral therapy (ART) on retention, virologic suppression,&#xD;
      and cost compared to the standard of care. The study will be conducted in Malawi and Zambia&#xD;
      among approximately 8,200 HIV-1-infected adults (18 years or older) who are stable on ART.&#xD;
      Clusters will be randomized to one of three study arms: (1) standard of care (SOC) ART&#xD;
      scripting (varies by country, region, clinic, and/or provider), (2) three-month ART&#xD;
      scripting, and (3) six-month ART scripting. 30 clusters will be selected for the study, 15 in&#xD;
      Malawi and 15 in Zambia, and will be randomized to a study arm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be conducted among approximately 8,200 HIV-infected individuals age 18 years&#xD;
      or older who are stable on antiretroviral therapy (ART) in 30 clusters in Malawi and Zambia.&#xD;
      Individuals will be screened at routine clinic visits and enrolled if they meet inclusion&#xD;
      criteria. Enrolled individuals will receive standard of care at their site with the exception&#xD;
      of their ART dispensing interval based on the assigned randomization. Outcomes will be&#xD;
      assessed after 12 months, but all participants will be under observational follow-up for 36&#xD;
      months, with annual re-assessment of retention, virologic suppression, and&#xD;
      cost-effectiveness.&#xD;
&#xD;
      There will be no contact with study participants during the period of follow-up.&#xD;
&#xD;
      Endpoints will be determined by chart review after the primary endpoint is reached (12&#xD;
      months). Endpoint data collection will include:&#xD;
&#xD;
        1. Retention in care on strategy&#xD;
&#xD;
        2. Suppressed viral load of &lt;1,000 copies done as part of standard of care viral load&#xD;
           monitoring&#xD;
&#xD;
      In a subset of participants in Malawi (n=1,500), we will perform a review of participants'&#xD;
      health passports, a record of patient clinic visits, general health information, and&#xD;
      medications that is possessed by patients in Malawi, after the 12-month endpoint has been&#xD;
      completed. Data will be collected on interim clinic visits, such as reason for visit/services&#xD;
      received (sick, family planning, non-communicable disease treatment), frequency of visits,&#xD;
      and location of clinic services.&#xD;
&#xD;
      In a subset of participants (~240), we will perform a post intervention study visit after the&#xD;
      12-month endpoint is completed. Qualitative interviews will be performed with a subset of&#xD;
      participants and will focus on patient experience with assigned dispensing interval,&#xD;
      including challenges/barriers and facilitators towards adherence and retention. Focused&#xD;
      questions around endpoints (if default, reasons; if virologic failure, reasons including&#xD;
      adherence) will also be addressed in the post-intervention visit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Enrollment completed. Outcomes measured after only 1 yr due to loss of funding.&#xD;
  </why_stopped>
  <start_date type="Actual">May 31, 2017</start_date>
  <completion_date type="Actual">August 10, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study will be a cluster randomized trial comparing three different antiretroviral therapy (ART) dispensing strategies. Clusters will be comprised of individual clinics in Malawi and Zambia. Enrolled individuals will receive standard of care at their site with the exception of the ART dispensing interval based on the assigned randomization. Outcomes will be assessed after 12 months.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retention in Care at 12 Months</measure>
    <time_frame>12 months</time_frame>
    <description>The primary outcome to be studied is whether scripting/dispensing of ART for intervals of six months is non-inferior to three months with respect to retention in care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Virologic Suppression at 12 Months</measure>
    <time_frame>12 months</time_frame>
    <description>The secondary outcome to be studied is whether scripting/dispensing of ART for intervals of six months is non-inferior to three months with respect to a viral load outcome of &lt;1,000 copies/ml (undetectable) at 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Provider Cost Per Patient by Outcome (USD) (Mean, 95% CI)</measure>
    <time_frame>12 months</time_frame>
    <description>The secondary outcome to be studied is the cost-effectiveness of scripting/dispensing of ART for intervals of six months compared to three months and SOC. Cost-effectiveness will be estimated as the average cost per successful outcome (patient retained at 12 months).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">9118</enrollment>
  <condition>HIV-1-infection</condition>
  <arm_group>
    <arm_group_label>Standard of care ART dispensing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The standard of care arm will allow ART dispensing based on usual practice at the clinic. Standard of care is anticipated to have variability in how ART is dispensed, although the approach should be consistent with applicable country guidelines at the time of study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Three-month ART dispensing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Providers at facilities randomized to three-month ART dispensing will be expected to provide all enrolled patients with a 90-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Six-month ART dispensing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Providers at facilities randomized to six-month ART dispensing will be expected to provide all enrolled patients with a 180-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Three-month ART dispensing</intervention_name>
    <description>Patients enrolled in the three-month ART dispensing arm will receive a 90-day supply of ART from their provider for the duration of the study.</description>
    <arm_group_label>Three-month ART dispensing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Six-month ART dispensing</intervention_name>
    <description>Patients enrolled in the six-month ART dispensing arm will receive a 180-day supply of ART from their provider for the duration of the study.</description>
    <arm_group_label>Six-month ART dispensing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
          -  Willing and able to provide written informed consent for participation in this study.&#xD;
&#xD;
          -  Confirmed HIV-1 infection based on country standard of care for testing.&#xD;
&#xD;
          -  On antiretroviral treatment (ART) for at least six months.&#xD;
&#xD;
          -  On a first-line ART regimen as defined by country-specific guidelines.&#xD;
&#xD;
          -  No drug toxicity/tolerability issues with ART regimen within the prior six months.&#xD;
&#xD;
          -  No period of more than one month without ART medication possession within the last six&#xD;
             months.&#xD;
&#xD;
          -  No active opportunistic infection suspected (including tuberculosis) and not treated&#xD;
             for an opportunistic infection in the last 30 days.&#xD;
&#xD;
          -  No active comorbidity (including hypertension) and not treated for a comorbidity in&#xD;
             the last 30 days.&#xD;
&#xD;
          -  No viral load of more than 1000 copies/ml (using standard assay) within the last six&#xD;
             months.&#xD;
&#xD;
          -  Not currently pregnant.&#xD;
&#xD;
          -  At least six months postpartum if recently delivered a baby.&#xD;
&#xD;
          -  Not currently breastfeeding or planning to breastfeed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years of age.&#xD;
&#xD;
          -  Viral load of 1000 copies/ml or greater (using standard assay) within the last six&#xD;
             months.&#xD;
&#xD;
          -  On alternative first-line or second-line ART regimen.&#xD;
&#xD;
          -  One month or more without medication possession within the last six months.&#xD;
&#xD;
          -  Experienced an ART toxicity/tolerability issue within the last six months.&#xD;
&#xD;
          -  Currently receiving treatment for tuberculosis or receiving treatment for any other&#xD;
             opportunistic infection or comorbidity (including hypertension).&#xD;
&#xD;
          -  Pregnant or less than six months postpartum.&#xD;
&#xD;
          -  Women who are breastfeeding.&#xD;
&#xD;
          -  Unwilling or unable to provide informed consent.&#xD;
&#xD;
          -  Previously enrolled in the study.&#xD;
&#xD;
          -  Currently enrolled in any other research study at the site that involves&#xD;
             adherence/retention or alters delivery of HIV care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Risa M Hoffman, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Partners in Hope</name>
      <address>
        <city>Lilongwe</city>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EQUIP Zambia</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malawi</country>
    <country>Zambia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>March 18, 2017</study_first_submitted>
  <study_first_submitted_qc>March 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2017</study_first_posted>
  <results_first_submitted>August 26, 2020</results_first_submitted>
  <results_first_submitted_qc>October 4, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 27, 2020</results_first_posted>
  <last_update_submitted>October 4, 2020</last_update_submitted>
  <last_update_submitted_qc>October 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Risa Hoffman, MD, MPH</investigator_full_name>
    <investigator_title>Associate Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>antiretroviral therapy</keyword>
  <keyword>retention</keyword>
  <keyword>ART</keyword>
  <keyword>cost-effectiveness</keyword>
  <keyword>virologic suppression</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 22, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT03101592/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment relied on active identification and referral of stable patients by clinic staff. Clinics were randomized to a study arm, and enrolled individuals initiated the study drug dispensing interval to which the clinic had been randomly assigned.&#xD;
A total of 14,430 individuals were screened from May 2017- April 2018 across 30 study sites.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care ART Dispensing</title>
          <description>The standard of care arm will allow ART dispensing based on usual practice at the clinic. Standard of care is anticipated to have variability in how ART is dispensed, although the approach should be consistent with applicable country guidelines at the time of study.</description>
        </group>
        <group group_id="P2">
          <title>Three-month ART Dispensing</title>
          <description>Providers at facilities randomized to three-month ART dispensing will be expected to provide all enrolled patients with a 90-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Three-month ART dispensing: Patients enrolled in the three-month ART dispensing arm will receive a 90-day supply of ART from their provider for the duration of the study.</description>
        </group>
        <group group_id="P3">
          <title>Six-month ART Dispensing</title>
          <description>Providers at facilities randomized to six-month ART dispensing will be expected to provide all enrolled patients with a 180-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Six-month ART dispensing: Patients enrolled in the six-month ART dispensing arm will receive a 180-day supply of ART from their provider for the duration of the study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3123"/>
                <participants group_id="P2" count="2896"/>
                <participants group_id="P3" count="3099"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3012"/>
                <participants group_id="P2" count="2726"/>
                <participants group_id="P3" count="2981"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="111"/>
                <participants group_id="P2" count="170"/>
                <participants group_id="P3" count="118"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>participant files could not be located</title>
              <participants_list>
                <participants group_id="P1" count="111"/>
                <participants group_id="P2" count="170"/>
                <participants group_id="P3" count="118"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline characteristics were summarized for just the participants for whom endpoint data was available. 399 participant files could not be located for recording outcome data, so they were excluded from these analyses.</population>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care ART Dispensing (SOC)</title>
          <description>The standard of care arm will allow ART dispensing based on usual practice at the clinic. Standard of care is anticipated to have variability in how ART is dispensed, although the approach should be consistent with applicable country guidelines at the time of study.</description>
        </group>
        <group group_id="B2">
          <title>Three-month ART Dispensing (3MD)</title>
          <description>Providers at facilities randomized to three-month ART dispensing will be expected to provide all enrolled patients with a 90-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Three-month ART dispensing: Patients enrolled in the three-month ART dispensing arm will receive a 90-day supply of ART from their provider for the duration of the study.</description>
        </group>
        <group group_id="B3">
          <title>Six-month ART Dispensing (6MD)</title>
          <description>Providers at facilities randomized to six-month ART dispensing will be expected to provide all enrolled patients with a 180-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Six-month ART dispensing: Patients enrolled in the six-month ART dispensing arm will receive a 180-day supply of ART from their provider for the duration of the study.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3012"/>
            <count group_id="B2" value="2726"/>
            <count group_id="B3" value="2981"/>
            <count group_id="B4" value="8719"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>clinics</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>For each demographic variable analyzed, some responses were missing, so could not be included.</population>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="2965"/>
                <count group_id="B2" value="2669"/>
                <count group_id="B3" value="2956"/>
                <count group_id="B4" value="8590"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.9" lower_limit="35.9" upper_limit="50.3"/>
                    <measurement group_id="B2" value="42.7" lower_limit="36.1" upper_limit="49.6"/>
                    <measurement group_id="B3" value="42.6" lower_limit="36.2" upper_limit="49.7"/>
                    <measurement group_id="B4" value="42.6" lower_limit="35.9" upper_limit="49.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>In the SOC arm, there was 1 missing data point for sex.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3011"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8718"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2020"/>
                    <measurement group_id="B2" value="1841"/>
                    <measurement group_id="B3" value="1913"/>
                    <measurement group_id="B4" value="5774"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="991"/>
                    <measurement group_id="B2" value="885"/>
                    <measurement group_id="B3" value="1068"/>
                    <measurement group_id="B4" value="2944"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="0"/>
                <count group_id="B2" value="0"/>
                <count group_id="B3" value="0"/>
                <count group_id="B4" value="0"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8719"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Malawi</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1532"/>
                    <measurement group_id="B2" value="1430"/>
                    <measurement group_id="B3" value="1588"/>
                    <measurement group_id="B4" value="4550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Zambia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1480"/>
                    <measurement group_id="B2" value="1296"/>
                    <measurement group_id="B3" value="1393"/>
                    <measurement group_id="B4" value="4169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Disclosure of HIV status to primary partner</title>
          <population>The number that disclosed HIV status was among those who reported having a primary partner. Additionally, there were missing/not answered data for each arm: in the standard of care arm, 3 were missing; in 3MD 3 were missing; and in 6MD, 1 was missing.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="2215"/>
                <count group_id="B2" value="2043"/>
                <count group_id="B3" value="2266"/>
                <count group_id="B4" value="6524"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2054"/>
                    <measurement group_id="B2" value="1819"/>
                    <measurement group_id="B3" value="2100"/>
                    <measurement group_id="B4" value="5973"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                    <measurement group_id="B2" value="224"/>
                    <measurement group_id="B3" value="166"/>
                    <measurement group_id="B4" value="551"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median years on ART</title>
          <population>Medians calculated among those with data available</population>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="2030"/>
                <count group_id="B2" value="1666"/>
                <count group_id="B3" value="1885"/>
                <count group_id="B4" value="5581"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.9" lower_limit="2.6" upper_limit="8.4"/>
                    <measurement group_id="B2" value="5.4" lower_limit="2.8" upper_limit="8.2"/>
                    <measurement group_id="B3" value="4.9" lower_limit="2.6" upper_limit="7.9"/>
                    <measurement group_id="B4" value="5.0" lower_limit="2.7" upper_limit="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Marital status</title>
          <population>In the 3MD arm and 6MD arm, there was 1 missing from each.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2725"/>
                <count group_id="B3" value="2980"/>
                <count group_id="B4" value="8717"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Married or long-term partner</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1889"/>
                    <measurement group_id="B2" value="1650"/>
                    <measurement group_id="B3" value="1977"/>
                    <measurement group_id="B4" value="5516"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Single or no long-term partner</title>
                  <measurement_list>
                    <measurement group_id="B1" value="247"/>
                    <measurement group_id="B2" value="248"/>
                    <measurement group_id="B3" value="267"/>
                    <measurement group_id="B4" value="762"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Widowed, divorced, or separated</title>
                  <measurement_list>
                    <measurement group_id="B1" value="876"/>
                    <measurement group_id="B2" value="827"/>
                    <measurement group_id="B3" value="736"/>
                    <measurement group_id="B4" value="2439"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median household size</title>
          <population>Calculated by arm and overall</population>
          <units>People in household</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8719"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="B2" value="5" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="B3" value="5" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="B4" value="4" lower_limit="3" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>School (highest level completed)</title>
          <population>Missing/not answered: SOC arm- 7; 3MD arm- 4; 6MD arm- 17</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3005"/>
                <count group_id="B2" value="2722"/>
                <count group_id="B3" value="2964"/>
                <count group_id="B4" value="8691"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>No education or less than primary school</title>
                  <measurement_list>
                    <measurement group_id="B1" value="574"/>
                    <measurement group_id="B2" value="480"/>
                    <measurement group_id="B3" value="347"/>
                    <measurement group_id="B4" value="1401"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Primary school</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1453"/>
                    <measurement group_id="B2" value="1293"/>
                    <measurement group_id="B3" value="1372"/>
                    <measurement group_id="B4" value="4118"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Secondary school</title>
                  <measurement_list>
                    <measurement group_id="B1" value="841"/>
                    <measurement group_id="B2" value="811"/>
                    <measurement group_id="B3" value="978"/>
                    <measurement group_id="B4" value="2630"/>
                  </measurement_list>
                </category>
                <category>
                  <title>University/Graduate</title>
                  <measurement_list>
                    <measurement group_id="B1" value="137"/>
                    <measurement group_id="B2" value="138"/>
                    <measurement group_id="B3" value="267"/>
                    <measurement group_id="B4" value="542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Work status</title>
          <population>6 missing/not answered from the SOC arm, 4 from the 3MD arm, and 4 from the 6MD arm</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3006"/>
                <count group_id="B2" value="2722"/>
                <count group_id="B3" value="2977"/>
                <count group_id="B4" value="8705"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Formal employment</title>
                  <measurement_list>
                    <measurement group_id="B1" value="450"/>
                    <measurement group_id="B2" value="398"/>
                    <measurement group_id="B3" value="629"/>
                    <measurement group_id="B4" value="1477"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Informal employment</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1435"/>
                    <measurement group_id="B2" value="1027"/>
                    <measurement group_id="B3" value="1545"/>
                    <measurement group_id="B4" value="4007"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not working</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1121"/>
                    <measurement group_id="B2" value="1297"/>
                    <measurement group_id="B3" value="803"/>
                    <measurement group_id="B4" value="3221"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Missed work to attend current ART clinic visit</title>
          <population>Missing/Unanswered for SOC arm = 8, 3MD arm = 6, 6MD arm =4.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3004"/>
                <count group_id="B2" value="2720"/>
                <count group_id="B3" value="2977"/>
                <count group_id="B4" value="8701"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1490"/>
                    <measurement group_id="B2" value="1101"/>
                    <measurement group_id="B3" value="1600"/>
                    <measurement group_id="B4" value="4191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Average monthly earnings</title>
          <population>Average monthly earnings among those who reported working in US dollars</population>
          <units>USD</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="1861"/>
                <count group_id="B2" value="1418"/>
                <count group_id="B3" value="2158"/>
                <count group_id="B4" value="5437"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.02" lower_limit="13.80" upper_limit="138.00"/>
                    <measurement group_id="B2" value="66.24" lower_limit="19.32" upper_limit="198.78"/>
                    <measurement group_id="B3" value="72.45" lower_limit="27.60" upper_limit="198.78"/>
                    <measurement group_id="B4" value="60.00" lower_limit="20.00" upper_limit="186.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Transport method to ART clinic</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8719"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Walk</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1786"/>
                    <measurement group_id="B2" value="1618"/>
                    <measurement group_id="B3" value="1306"/>
                    <measurement group_id="B4" value="4710"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Bicycle</title>
                  <measurement_list>
                    <measurement group_id="B1" value="339"/>
                    <measurement group_id="B2" value="304"/>
                    <measurement group_id="B3" value="385"/>
                    <measurement group_id="B4" value="1028"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Bus or minibus</title>
                  <measurement_list>
                    <measurement group_id="B1" value="770"/>
                    <measurement group_id="B2" value="634"/>
                    <measurement group_id="B3" value="925"/>
                    <measurement group_id="B4" value="2329"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Bicycle taxi</title>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="237"/>
                    <measurement group_id="B4" value="398"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Personal or friend's vehicle</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="119"/>
                    <measurement group_id="B4" value="216"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median one-way travel time to clinic</title>
          <population>Medians overall and by arm among those for whom data were reported.</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8719"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.2" lower_limit="19.8" upper_limit="66.5"/>
                    <measurement group_id="B2" value="45.0" lower_limit="25.2" upper_limit="90.0"/>
                    <measurement group_id="B3" value="40.2" lower_limit="19.8" upper_limit="60.0"/>
                    <measurement group_id="B4" value="40.3" lower_limit="20.0" upper_limit="80.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Proportion of patients incurring transport costs to clinic</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8719"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="917"/>
                    <measurement group_id="B2" value="812"/>
                    <measurement group_id="B3" value="1265"/>
                    <measurement group_id="B4" value="2994"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>For those incurring transport costs, median one-way cost</title>
          <population>For those who did incur transport costs.</population>
          <units>USD</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="917"/>
                <count group_id="B2" value="812"/>
                <count group_id="B3" value="1265"/>
                <count group_id="B4" value="2994"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.69" lower_limit="0.30" upper_limit="1.0"/>
                    <measurement group_id="B2" value="0.55" lower_limit="0.40" upper_limit="0.97"/>
                    <measurement group_id="B3" value="0.69" lower_limit="0.41" upper_limit="1.38"/>
                    <measurement group_id="B4" value="0.69" lower_limit="0.40" upper_limit="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median time spent at ART clinic</title>
          <population>Medians by arm and overall.</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="3012"/>
                <count group_id="B2" value="2726"/>
                <count group_id="B3" value="2981"/>
                <count group_id="B4" value="8719"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120.0" lower_limit="60.0" upper_limit="180.0"/>
                    <measurement group_id="B2" value="180.0" lower_limit="120.0" upper_limit="240.0"/>
                    <measurement group_id="B3" value="180.0" lower_limit="120.0" upper_limit="240.0"/>
                    <measurement group_id="B4" value="150.0" lower_limit="90.0" upper_limit="240.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median ART dispensing interval in year prior</title>
          <population>Medians by arm and overall</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="2208"/>
                <count group_id="B2" value="2084"/>
                <count group_id="B3" value="2197"/>
                <count group_id="B4" value="6489"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.0" lower_limit="43.0" upper_limit="90.0"/>
                    <measurement group_id="B2" value="80.0" lower_limit="60.0" upper_limit="90.0"/>
                    <measurement group_id="B3" value="78.0" lower_limit="60.0" upper_limit="90.0"/>
                    <measurement group_id="B4" value="75.0" lower_limit="54.0" upper_limit="90.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Among reproductive age women, received contraception in last three months</title>
          <population>This variable was just among women of reproductive age. In each arm, there were missing/unanswered among this group: in the SOC arm= 204, 3MD arm = 212, 6MD arm = 220.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="1001"/>
                <count group_id="B2" value="962"/>
                <count group_id="B3" value="1035"/>
                <count group_id="B4" value="2998"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>clinics</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="10"/>
                <count group_id="B2" value="10"/>
                <count group_id="B3" value="10"/>
                <count group_id="B4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="139"/>
                    <measurement group_id="B2" value="155"/>
                    <measurement group_id="B3" value="214"/>
                    <measurement group_id="B4" value="508"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Retention in Care at 12 Months</title>
        <description>The primary outcome to be studied is whether scripting/dispensing of ART for intervals of six months is non-inferior to three months with respect to retention in care.</description>
        <time_frame>12 months</time_frame>
        <population>The sample includes only those participants for whom outcome data was available (n=8719). As described in the participant flow, 399 participant files could not be located to analyze final outcome data at the endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care ART Dispensing (SOC)</title>
            <description>The standard of care arm will allow ART dispensing based on usual practice at the clinic. Standard of care is anticipated to have variability in how ART is dispensed, although the approach should be consistent with applicable country guidelines at the time of study.</description>
          </group>
          <group group_id="O2">
            <title>Three-month ART Dispensing (3MD)</title>
            <description>Providers at facilities randomized to three-month ART dispensing will be expected to provide all enrolled patients with a 90-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Three-month ART dispensing: Patients enrolled in the three-month ART dispensing arm will receive a 90-day supply of ART from their provider for the duration of the study.</description>
          </group>
          <group group_id="O3">
            <title>Six-month ART Dispensing (6MD)</title>
            <description>Providers at facilities randomized to six-month ART dispensing will be expected to provide all enrolled patients with a 180-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Six-month ART dispensing: Patients enrolled in the six-month ART dispensing arm will receive a 180-day supply of ART from their provider for the duration of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Retention in Care at 12 Months</title>
          <description>The primary outcome to be studied is whether scripting/dispensing of ART for intervals of six months is non-inferior to three months with respect to retention in care.</description>
          <population>The sample includes only those participants for whom outcome data was available (n=8719). As described in the participant flow, 399 participant files could not be located to analyze final outcome data at the endpoint.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3012"/>
                <count group_id="O2" value="2726"/>
                <count group_id="O3" value="2981"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Retention</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2478"/>
                    <measurement group_id="O2" value="2356"/>
                    <measurement group_id="O3" value="2729"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Transfer</title>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                    <measurement group_id="O2" value="66"/>
                    <measurement group_id="O3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Lost to follow-up</title>
                  <measurement_list>
                    <measurement group_id="O1" value="463"/>
                    <measurement group_id="O2" value="296"/>
                    <measurement group_id="O3" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>4.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.3</ci_lower_limit>
            <ci_upper_limit>12.3</ci_upper_limit>
            <estimate_desc>RD is for retention 3MD vs. SOC.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>9.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>17.2</ci_upper_limit>
            <estimate_desc>RD is for retention 6MD vs. SOC.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1</ci_lower_limit>
            <ci_upper_limit>9.1</ci_upper_limit>
            <estimate_desc>RD is for retention 6MD vs. 3MD.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.8</ci_lower_limit>
            <ci_upper_limit>1.6</ci_upper_limit>
            <estimate_desc>RD is for transfer 3MD vs. SOC.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.9</ci_lower_limit>
            <ci_upper_limit>0.8</ci_upper_limit>
            <estimate_desc>RD is for transfer 6MD vs. SOC.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.7</ci_lower_limit>
            <ci_upper_limit>0.7</ci_upper_limit>
            <estimate_desc>RD is for transfer 6MD vs. 3MD.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.4</ci_lower_limit>
            <ci_upper_limit>0.2</ci_upper_limit>
            <estimate_desc>RD is for death 3MD vs. SOC.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.9</ci_lower_limit>
            <ci_upper_limit>0.8</ci_upper_limit>
            <estimate_desc>RD is for death 6MD vs. SOC.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Our sample size was estimated for a cluster-randomized non-inferiority trial. We had 30 clusters available for randomization and assumed a fixed number of clusters (k), an equal number of clusters per arm, and an equal number of subjects per cluster.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>We estimated that approximately 5% of subjects would fail to be retained in care in the standard of care arm, and a retention rate &lt;75% to be non-inferior in the three-month or six-month study arms, with a 25% non-inferiority margin. Assuming an alpha of 0.05, power of 90%, and an intracluster correlation coefficient (ICC) of 0004, we estimated a sample size of 271 subjects per cluster for a total of 2,710 subjects per arm and 8,130 total individuals.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.3</ci_lower_limit>
            <ci_upper_limit>0.3</ci_upper_limit>
            <estimate_desc>RD is for death 6MD vs. 3MD.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Virologic Suppression at 12 Months</title>
        <description>The secondary outcome to be studied is whether scripting/dispensing of ART for intervals of six months is non-inferior to three months with respect to a viral load outcome of &lt;1,000 copies/ml (undetectable) at 12 months.</description>
        <time_frame>12 months</time_frame>
        <population>Viral load was originally listed as a secondary outcome. However, given the nature of this implementation science project, and under real world conditions, Viral Load testing was not done due to the early state of viral load scale-up in both Malawi and Zambia.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care ART Dispensing (SOC)</title>
            <description>The standard of care arm will allow ART dispensing based on usual practice at the clinic. Standard of care is anticipated to have variability in how ART is dispensed, although the approach should be consistent with applicable country guidelines at the time of study.</description>
          </group>
          <group group_id="O2">
            <title>Three-month ART Dispensing (3MD)</title>
            <description>Providers at facilities randomized to three-month ART dispensing will be expected to provide all enrolled patients with a 90-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Three-month ART dispensing: Patients enrolled in the three-month ART dispensing arm will receive a 90-day supply of ART from their provider for the duration of the study.</description>
          </group>
          <group group_id="O3">
            <title>Six-month ART Dispensing (6MD)</title>
            <description>Providers at facilities randomized to six-month ART dispensing will be expected to provide all enrolled patients with a 180-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Six-month ART dispensing: Patients enrolled in the six-month ART dispensing arm will receive a 180-day supply of ART from their provider for the duration of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Virologic Suppression at 12 Months</title>
          <description>The secondary outcome to be studied is whether scripting/dispensing of ART for intervals of six months is non-inferior to three months with respect to a viral load outcome of &lt;1,000 copies/ml (undetectable) at 12 months.</description>
          <population>Viral load was originally listed as a secondary outcome. However, given the nature of this implementation science project, and under real world conditions, Viral Load testing was not done due to the early state of viral load scale-up in both Malawi and Zambia.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Provider Cost Per Patient by Outcome (USD) (Mean, 95% CI)</title>
        <description>The secondary outcome to be studied is the cost-effectiveness of scripting/dispensing of ART for intervals of six months compared to three months and SOC. Cost-effectiveness will be estimated as the average cost per successful outcome (patient retained at 12 months).</description>
        <time_frame>12 months</time_frame>
        <population>For the cost analysis, we excluded 179 participants whose visit data were unclear, leaving an analytic sample of 8,540 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Malawi: Standard of Care (SOC)</title>
            <description>Patients in the standard of care arm in Malawi.</description>
          </group>
          <group group_id="O2">
            <title>Malawi: 3 Month Dispensing (3MD)</title>
            <description>Patients in the 3 month dispensing arm in Malawi.</description>
          </group>
          <group group_id="O3">
            <title>Malawi: 6 Month Dispensing (6MD)</title>
            <description>Patients in the 6 month dispensing arm in Malawi.</description>
          </group>
          <group group_id="O4">
            <title>Zambia: Standard of Care (SOC)</title>
            <description>Patients in the standard of care arm in Zambia.</description>
          </group>
          <group group_id="O5">
            <title>Zambia: 3 Month Dispensing (3MD)</title>
            <description>Patients in the 3 month dispensing arm in Zambia.</description>
          </group>
          <group group_id="O6">
            <title>Zambia: 6 Month Dispensing (6MD)</title>
            <description>Patients in the 6 month dispensing arm in Zambia.</description>
          </group>
        </group_list>
        <measure>
          <title>Provider Cost Per Patient by Outcome (USD) (Mean, 95% CI)</title>
          <description>The secondary outcome to be studied is the cost-effectiveness of scripting/dispensing of ART for intervals of six months compared to three months and SOC. Cost-effectiveness will be estimated as the average cost per successful outcome (patient retained at 12 months).</description>
          <population>For the cost analysis, we excluded 179 participants whose visit data were unclear, leaving an analytic sample of 8,540 patients.</population>
          <units>US Dollars</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1328"/>
                <count group_id="O2" value="1224"/>
                <count group_id="O3" value="1465"/>
                <count group_id="O4" value="1101"/>
                <count group_id="O5" value="1056"/>
                <count group_id="O6" value="1241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Achieved primary outcome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.00" lower_limit="87.90" upper_limit="91.90"/>
                    <measurement group_id="O2" value="88.40" lower_limit="86.44" upper_limit="90.36"/>
                    <measurement group_id="O3" value="85.92" lower_limit="83.97" upper_limit="87.89"/>
                    <measurement group_id="O4" value="143.60" lower_limit="141.68" upper_limit="145.60"/>
                    <measurement group_id="O5" value="141.60" lower_limit="139.64" upper_limit="143.56"/>
                    <measurement group_id="O6" value="131.13" lower_limit="129.20" upper_limit="133.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Did not achieve primary outcome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.40" lower_limit="61.42" upper_limit="65.37"/>
                    <measurement group_id="O2" value="62.30" lower_limit="60.35" upper_limit="64.30"/>
                    <measurement group_id="O3" value="66.10" lower_limit="64.12" upper_limit="68.09"/>
                    <measurement group_id="O4" value="99.00" lower_limit="97.04" upper_limit="100.98"/>
                    <measurement group_id="O5" value="99.00" lower_limit="97.04" upper_limit="100.98"/>
                    <measurement group_id="O6" value="99.00" lower_limit="96.98" upper_limit="100.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All patients</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.50" lower_limit="84.50" upper_limit="88.42"/>
                    <measurement group_id="O2" value="86.00" lower_limit="83.99" upper_limit="87.91"/>
                    <measurement group_id="O3" value="84.60" lower_limit="82.62" upper_limit="86.54"/>
                    <measurement group_id="O4" value="132.00" lower_limit="130.43" upper_limit="134.35"/>
                    <measurement group_id="O5" value="134.00" lower_limit="132.09" upper_limit="136.02"/>
                    <measurement group_id="O6" value="128.00" lower_limit="125.64" upper_limit="129.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment through 1 year of follow-up with all participants</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard of Care ART Dispensing (SOC)</title>
          <description>The standard of care arm will allow ART dispensing based on usual practice at the clinic. Standard of care is anticipated to have variability in how ART is dispensed, although the approach should be consistent with applicable country guidelines at the time of study.</description>
        </group>
        <group group_id="E2">
          <title>Three-month ART Dispensing (3MD)</title>
          <description>Providers at facilities randomized to three-month ART dispensing will be expected to provide all enrolled patients with a 90-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Three-month ART dispensing: Patients enrolled in the three-month ART dispensing arm will receive a 90-day supply of ART from their provider for the duration of the study.</description>
        </group>
        <group group_id="E3">
          <title>Six-month ART Dispensing (6MD)</title>
          <description>Providers at facilities randomized to six-month ART dispensing will be expected to provide all enrolled patients with a 180-day supply of ART and associated HIV medications (cotrimoxazole and isoniazid if part of country guidelines). All other aspects of care will be as per standard of care for the enrolling clinic.&#xD;
Six-month ART dispensing: Patients enrolled in the six-month ART dispensing arm will receive a 180-day supply of ART from their provider for the duration of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="3012"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2726"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2981"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3012"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2726"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2981"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3012"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2726"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2981"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>As an implementation science study of service delivery, we faced limitations common in real-world interventions. Most participants did not have routine viral load tests and funding limitations reduced the follow-up period to one year.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine</name_or_title>
      <organization>David Geffen School of Medicine at UCLA</organization>
      <phone>310 825-7225</phone>
      <email>rhoffman@mednet.ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

